kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
---|---|---|
Total revenue | 42.11%1.95B | 1.37B |
Operating revenue | 42.11%1.95B | --1.37B |
Cost of revenue | 29.32%1.29B | 1B |
Gross profit | 76.35%659.29M | 373.86M |
Operating expense | 34.67%595.33M | 442.07M |
Operating profit | 193.76%63.96M | -68.22M |
Net non-operating interest income /expenses | -26.91%-21.58M | -17.01M |
Non-operating interest income | 0.00%1K | --1K |
Non-operating interest expense | 26.91%21.58M | --17.01M |
Other net income /expenses | ||
Special income /charges | -117.18%-11.14M | ---5.13M |
-Less:Other special charges | 117.18%11.14M | --5.13M |
Other non-operating income /expenses | -61.20%13.78M | --35.52M |
Income before tax | 182.11%45.02M | -54.83M |
Income tax | 186.28%17.18M | ---19.91M |
Net income | 179.73%27.84M | -34.92M |
Net income continuous operations | 179.73%27.85M | ---34.93M |
Net income attributable to the company | 179.73%27.84M | -34.92M |
Other under preferred stock dividend | --0 | --0 |
Net income attributable to common stockholders | 179.73%27.84M | -34.92M |
Diluted earnings per share | 179.73%92.8133 | ---116.4133 |
Basic earnings per share | 179.73%92.8133 | ---116.4133 |
Currency Unit | JPY | JPY |